Synthesis and biological activities of methylenebis-4H-1,2,4-triazole derivatives

5,5'-Methylenebis(4--phenyl-4H-1,2,4-triazole-3-thiol) (2) was synthesized starting from hydrazinecarbothioamide compound (1). Treatment of compound 2 with ethyl bromoacetate produced diethyl 5,5'-{methylenebis[(4-phenyl-4H-1,2,4-triazole-5,3-diyl)thio]}diacetate (3), which was converted to the corresponding diacetohydrazide derivative (4) by treatment with hydrazine hydrate. The reaction of compound 4 with several aldehydes produced the corresponding arylidene hydrazides, 5a--d. Syntheses of Mannich bases 6a--c were carried out by the treatment of compound 2 with several amines in the presence of formaldehyde. (4{[5-({5-[(4-Amino-2-chlorophenyl)thio]-4-phenyl-4H-1,2,4-triazol-3-ylmethyl)-4-phenyl-4H-1,2,4-triazol-3-yl]thio}-3-chlorophenyl)amine (8) was prepared by reduction of 2 nitro groups of 3,3' -methylenebis{5-[(2-chloro-4-nitrophenyl)thio]-4-phenyl-4H-1,2,4-triazole} (7) that were obtained from the condensation of 2} with 3,4-dichloronitrobenzene. The newly synthesized compounds were screened for their antimicrobial activities; some of them were found to be active towards the test microorganisms as the results demonstrated that the synthesized compounds exhibited a broad spectrum of activity with minimum inhibitory concentration (MIC) values of 31.3--500 m g/mL against gram-positive and gram-negative bacteria, Candia albicans and Saccharomyces cerevisiae. All compounds displayed lower activity in this series against the microorganisms with MIC values of 31.3--500 m g/mL than did the compared control drugs of ampicillin, streptomycin, and fluconazole.

Anahtar Kelimeler:

1, 2, 4-Triazole, morpholine, furan, Schiff base, Mannich base, antimicrobial activity

Synthesis and biological activities of methylenebis-4H -1,2,4-triazole derivatives

Keywords:

1, 2, 4-Triazole, morpholine, furan, Schiff base, Mannich base, antimicrobial activity,

PDF

___

Heindel, N. D.; Reid, I. R. J. Heterocycl. Chem. 1980, 17, 1087–1088.
Holla, B. S.; Kalluraya, B.; Sridhar, K. R.; Drake, E.; Thomas, L. M.; Bhandary, K. K.; Levine, M. S. Eur. J. Med. Chem. 1994, 29, 301–308.
Merk and Co. The Merk Index, 12th ed., Merk and Co. Inc., Whitehouse Station, NJ, USA, 1996.
Haber, J. Cas. Lek. Cesk. 2001, 140, 596–604.
Lee, S.; Kamide, T.; Tabata, H.; Takahashi, H.; Shiro, M.; Natsugari, H. Bioorg. Med. Chem. 2008, 16, 9519–9523. Chaytor, A. In xPharm: The Comprehensive Pharmacology Reference; Enna, S. J.; Bylund, D. B., Eds.; Elsevier, Amsterdam, 2007.
Subrahmanya, B. K.; Poojary, B.; Jagadeesh P. D.; Naik, P.; Holla, B. S. Eur. J. Med. Chem. 2009, 44, 5066–5070. Kumarapperuma, S. C.; Sun, Y.; Jeselnik, M.; Chung, K.; Parker, W. B.; Jonsson, C. B.; Arterburn, J. B. Bioorg. Med. Chem. Lett. 2007, 17, 3203–3207.
Prasad, D. J.; Ashok, M.; Karegoudar, P.; Poojary, B.; Holla, B. S.; Kumari, N. S. Eur. J. Med. Chem. 2009, 44, 551–557.
Jin, Z.; Hu, Y.; Huo, A.; Tao, W.; Shao, L.; Liu, J.; Fang, J. J. Organometallic Chem. 2006, 691, 2340–2345.
Bhat, K. S.; Poojary, B.; Prasad, D. J.; Naik, P.; Holla, B. S. Eur. J. Med. Chem. 2009, 44, 5066–5070.
Dahlof, C. G. H.; Rapoport, A. M.; Sheftell, F. D.; Lines, C. R. Clin. Ther. 1999, 21, 1823–1836.
Faidallah, H. M.; Khan, K. A.; Asiri, A. M. J. Fluorine Chem. 2011, 132, 870–877.
Turan-Zitouni, G.; Kaplancikli, Z. A.; Yildiz, M. T.; Chevallet, P.; Kaya, D. Eur. J. Med. Chem. 2005, 40, 607–613. Akbas, E.; Berber, I. Eur. J. Med. Chem. 2005, 40, 401–405.
Bayrak, H.; Demirba¸s, A.; Belkta¸s, H.; Karao˘ glu, S ¸. A.; Demirba¸s, N. Turk. J. Chem. 2010, 34, 835–846.
Bayrak, H.; Demirbas, A.; Demirbas, N.; Karaoglu, S. A. Eur. J. Med. Chem. 2009, 44, 4362–4366.
Bayrak, H.; Demirbas, A.; Karaoglu, S. A.; Demirbas, N. Eur. J. Med. Chem. 2009, 44, 1057–1066.
Wyrzykiewicz, E.; Prukala, D. J. Heterocyclic Chem. 1998, 35, 381–387.
Galic, N.; Peric, B.; Kojic-Prodic, B.; Cimerman, Z. J. Mol. Struct. 2001, 559, 187–194.
Rando, D.; Sato, D. N.; Siqueira, L.; Malvezzi, A.; Leite, C. Q. F.; Amaral, A. T.; Ferreira, E. I.; Tavares, L. C. Bioorg. Med. Chem. 2002, 10, 557–560.
NCCLS. NCCLS Document M7-A3, NCCLS, Villanova, PA, USA, 1993.